Previous research showed that PLOD2 was highly expressed in various cancer types, including hepatocellular carcinoma (HCC), oral squamous cell carcinoma (OSCC), gastric cancer and lung cancer. Here, PLOD2 is linked to hepatocellular carcinoma.